These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29027155)

  • 1. The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy.
    Yang R; Hung MC
    Sci China Life Sci; 2017 Oct; 60(10):1058-1064. PubMed ID: 29027155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action.
    Du W; Yang M; Turner A; Xu C; Ferris RL; Huang J; Kane LP; Lu B
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28300768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tim-3 and its role in regulating anti-tumor immunity.
    Das M; Zhu C; Kuchroo VK
    Immunol Rev; 2017 Mar; 276(1):97-111. PubMed ID: 28258697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Galectin-9 Treatment on the Phenotype and Function of NK-92MI Cells in the Presence of Different Serum Supplements.
    Meggyes M; Nagy DU; Balassa T; Godony K; Peterfalvi A; Szereday L; Polgar B
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy.
    Yang R; Sun L; Li CF; Wang YH; Yao J; Li H; Yan M; Chang WC; Hsu JM; Cha JH; Hsu JL; Chou CW; Sun X; Deng Y; Chou CK; Yu D; Hung MC
    Nat Commun; 2021 Feb; 12(1):832. PubMed ID: 33547304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
    Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
    Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors.
    Komita H; Koido S; Hayashi K; Kan S; Ito M; Kamata Y; Suzuki M; Homma S
    Oncol Rep; 2015 Oct; 34(4):2099-105. PubMed ID: 26239720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.
    Liu Y; Ji H; Zhang Y; Shen X; Gao F; He X; Li GA; Busuttil RW; Kuchroo VK; Kupiec-Weglinski JW
    J Hepatol; 2015 Mar; 62(3):563-72. PubMed ID: 25450716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIM-3: An update on immunotherapy.
    Zhao L; Cheng S; Fan L; Zhang B; Xu S
    Int Immunopharmacol; 2021 Oct; 99():107933. PubMed ID: 34224993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.
    Kanzaki M; Wada J; Sugiyama K; Nakatsuka A; Teshigawara S; Murakami K; Inoue K; Terami T; Katayama A; Eguchi J; Akiba H; Yagita H; Makino H
    Endocrinology; 2012 Feb; 153(2):612-20. PubMed ID: 22186414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4
    Zhuo Y; Zhang YF; Wu HJ; Qin L; Wang YP; Liu AM; Wang XH
    Biomed Pharmacother; 2017 Oct; 94():386-393. PubMed ID: 28772217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Tim-3 in regulating tumorigenesis, inflammation, and antitumor immunity therapy.
    Cao Y; Li Q; Liu H; He X; Huang F; Wang Y
    Cancer Biomark; 2021; 32(2):237-248. PubMed ID: 34092621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of T-cell immunoglobulin mucin molecule 3 and its ligand galectin-9 in patients with adenomyosis.
    Huang P; Lv C; Zhang C; Feng H; Li C; Zhang H; Zhao X; Li M
    Gynecol Endocrinol; 2020 Jul; 36(7):605-610. PubMed ID: 32319832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oridonin Could Inhibit Inflammation and T-cell Immunoglobulin and Mucin-3/Galectin-9 (TIM-3/Gal-9) Autocrine Loop in the Acute Myeloid Leukemia Cell Line (U937) as Compared to Doxorubicin.
    Nasri F; Sadeghi F; Behranvand N; Samei A; Bolouri MR; Azari T; Abdollahi E; Ghazizadeh F; Motevalian M; Hassan ZM; Falak R
    Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):602-611. PubMed ID: 33463129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TIM-3 in ovarian cancer.
    Xu Y; Zhang H; Huang Y; Rui X; Zheng F
    Clin Transl Oncol; 2017 Sep; 19(9):1079-1083. PubMed ID: 28357631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-9 contributes to the pathogenesis of atopic dermatitis
    Su W; Zhang J; Yang S; Tang M; Shen Y; Liu C; Ji J; Maurer M; Jiao Q
    Front Immunol; 2022; 13():952338. PubMed ID: 35967337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer.
    Yasinska IM; Sakhnevych SS; Pavlova L; Teo Hansen Selnø A; Teuscher Abeleira AM; Benlaouer O; Gonçalves Silva I; Mosimann M; Varani L; Bardelli M; Hussain R; Siligardi G; Cholewa D; Berger SM; Gibbs BF; Ushkaryov YA; Fasler-Kan E; Klenova E; Sumbayev VV
    Front Immunol; 2019; 10():1594. PubMed ID: 31354733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Tim-3 functions in antimicrobial and tumor immunity.
    Sakuishi K; Jayaraman P; Behar SM; Anderson AC; Kuchroo VK
    Trends Immunol; 2011 Aug; 32(8):345-9. PubMed ID: 21697013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and Functions of T-cell Immunoglobulin-domain and Mucin- domain Protein 3 in Cancer.
    Lu X
    Curr Med Chem; 2022; 29(11):1851-1865. PubMed ID: 34365943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.